Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Drugs/Products That May Increase Cancer Risk
  5. Other

Other

  • Anemia (42)
  • Blood Products (4)
  • Breast Cancer (65)
  • Cancer (17)
  • Cervical Cancer (14)
  • Chemotherapy (4)
  • Chemotherapy-Induced Adverse Effects (34)
  • Colon Cancer (14)
  • Drugs/Products That May Increase Cancer Risk (85)
    • Drugs (62)
    • Natural Medicines/Supplements (8)
    • Other (15)
  • Gastrointestinal Cancers (24)
  • Hemophilia (2)
  • Hemorrhage (6)
  • Leukemia (1)
  • Lung Cancer (77)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (1)
  • Prostate Cancer (17)
  • Renal Cancer (1)
  • Resources (56)
  • Sickle Cell Disease (4)
  • Skin Cancer (20)
1 - 15 of 15 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
FAQ: E-Cigarettes and Vaping January 2022
Toolbox: Smoking Cessation: Helping Patients Who Use Tobacco September 2020
Article: Watch for Changes to Chantix and Bupropion Labeling February 2017
Other: Chantix and Zyban Mental Health Side Effects Revised February 2017
Commentary: Electronic Cigarettes and Hookah Pipes: Safety and Regulations Update June 2014
Article: efforts to reduce nicotine toxicity associated with e-cigarettes June 2014
Commentary: FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions January 2014
Article: You'll continue to hear buzz about Avandia (rosiglitazone) January 2014
Article: whether electronic cigarettes or hookah pipes are safer than smoking cigarettes May 2013
Commentary: Potassium Iodide (KI): Frequently Asked Questions April 2011
Commentary: Compounding KI for Radiation Exposure April 2011
Article: potassium iodide for radiation exposure April 2011
Article: possible link between plastics containing bisphenol A (BPA) and diabetes and heart disease November 2008
Guideline: National Kidney Foundation Guideline and Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target June 2007
Commentary: Safe Use of Erythropoiesis-Stimulating Agents (ESAs) June 2007
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved